Probiotic Infant Use Raises FDA, Food Advisory Committee Concern
This article was originally published in The Tan Sheet
Executive Summary
FDA expressed concerns regarding a 75-day premarket notification for a probiotic containing Lactobacillus reuteri due to inadequate information on the bacteria's safety in infants and young children. The notification was submitted June 30 by McNeil Consumer Healthcare.